                               SEQUENCE LISTING

<110> ABEXXA BIOLOGICS, INC.
 
<120> ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL 
      HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

<130> 50626-706.601

<140>
<141>

<150> 62/702,143
<151> 2018-07-23

<160> 38    

<170> PatentIn version 3.5

<210> 1
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gln Ser Ile Ser Ser Tyr 
1               5       


<210> 2
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Asn Ala Ala 
1           


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gln Gln Ala Ala Thr Tyr Pro Ala Thr 
1               5                   


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210> 5
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ile Ala Tyr Gly Gly Gly Ala Thr 
1               5               


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Ala Lys Gly Leu Ser Asn Phe Asp Tyr 
1               5                   


<210> 7
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asn Ala Ala Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Ala Thr Tyr Pro Ala 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 8
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Arg Ile Ala Tyr Gly Gly Gly Ala Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Leu Ser Asn Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210> 9
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Ser Ser Val Ser Tyr 
1               5   


<210> 10
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Ser Thr Ser 
1           


<210> 11
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Gln Gln Arg Ser Ser Tyr Pro Pro Thr 
1               5                   


<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Gly Tyr Thr Phe Thr Asp Tyr Val 
1               5               


<210> 13
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Ile Tyr Pro Gly Asn Asn Thr Thr 
1               5               


<210> 14
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ala Arg Glu Ser Leu Gly Ile Tyr Tyr Gly Ser Thr Tyr Lys Gly Leu 
1               5                   10                  15      


Tyr Ala Met Asp Tyr 
            20      


<210> 15
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 15
Gln Ile Val Leu Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly 
1               5                   10                  15      


Glu Lys Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met 
            20                  25                  30          


His Trp Phe Gln Gln Lys Pro Gly Thr Ser Pro Lys Leu Trp Ile Tyr 
        35                  40                  45              


Ser Thr Ser Asn Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser 
    50                  55                  60                  


Gly Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Arg Met Glu Ala Glu 
65                  70                  75                  80  


Asp Ala Ala Thr Tyr Tyr Cys Gln Gln Arg Ser Ser Tyr Pro Pro Thr 
                85                  90                  95      


Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys Arg Thr 
            100                 105             


<210> 16
<211> 128
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 16
Gln Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Val Ile Ser Trp Val Lys Gln Arg Thr Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Tyr Pro Gly Asn Asn Thr Thr Tyr Tyr Asn Asp Asn Phe 
    50                  55                  60                  


Arg Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ser Leu Gly Ile Tyr Tyr Gly Ser Thr Tyr Lys Gly Leu 
            100                 105                 110         


Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Thr Leu Thr Val Ser Ser 
        115                 120                 125             


<210> 17
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Gly Ile Ile Phe Ser Asp Tyr Arg 
1               5               


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Ile Ser Thr Gly Gly Ser Ile 
1               5           


<210> 19
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Asn Ala Gly Leu Arg 
1               5   


<210> 20
<211> 113
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 20
Met Ala Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Ala 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Thr Cys Val Ala Ser Gly Ile Ile Phe Ser 
            20                  25                  30          


Asp Tyr Arg Val Ala Trp Tyr Arg Gln Ala Pro Gly Lys Gln Arg Glu 
        35                  40                  45              


Leu Val Ala Arg Ile Ser Thr Gly Gly Ser Ile Leu Tyr Ala Asp Ser 
    50                  55                  60                  


Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Val 
65                  70                  75                  80  


Asn Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Asn Ala Gly Leu Arg Trp Gly Gln Gly Thr Gln Val Thr Val Ser 
            100                 105                 110         


Ser 
    


<210> 21
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Gly Arg Thr Phe Ser Arg Ala Thr 
1               5               


<210> 22
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Ile Arg Trp Ser Thr Glu Ser Thr 
1               5               


<210> 23
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Ala Thr Asp Leu Ser Thr Tyr Tyr Gly Ala Ile Asp Thr Gly Ala Asp 
1               5                   10                  15      


Asp Tyr Asp Tyr 
            20  


<210> 24
<211> 129
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 24
Met Ala Gln Val Thr Leu Lys Glu Ser Gly Gly Gly Leu Val Gln Ala 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Arg Thr Phe Ser 
            20                  25                  30          


Arg Ala Thr Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu 
        35                  40                  45              


Phe Val Ala Gly Ile Arg Trp Ser Thr Glu Ser Thr Tyr Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Arg Ala Lys Asn Thr 
65                  70                  75                  80  


Val Tyr Leu Asp Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Ala Tyr 
                85                  90                  95      


Tyr Cys Ala Thr Asp Leu Ser Thr Tyr Tyr Gly Ala Ile Asp Thr Gly 
            100                 105                 110         


Ala Asp Asp Tyr Asp Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210> 25
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Gly Arg Ile Ser Thr Thr Tyr Ala 
1               5               


<210> 26
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Ile Tyr Trp Ser Gly Gly Met Thr 
1               5               


<210> 27
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Ala Ala Asp Pro Arg Ala Ala Tyr Tyr Tyr Gly Thr Ser Asp Tyr Thr 
1               5                   10                  15      


Leu Pro Gly Arg Tyr Asn Asn 
            20              


<210> 28
<211> 132
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 28
Met Ala Gln Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Gln Pro 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Arg Ile Ser Thr 
            20                  25                  30          


Thr Tyr Ala Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu 
        35                  40                  45              


Phe Val Ala Ala Ile Tyr Trp Ser Gly Gly Met Thr Lys Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Ser Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr 
65                  70                  75                  80  


Val Leu Leu Gln Met Asn Ser Leu Lys Ser Gly Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Ala Asp Pro Arg Ala Ala Tyr Tyr Tyr Gly Thr Ser Asp 
            100                 105                 110         


Tyr Thr Leu Pro Gly Arg Tyr Asn Asn Trp Gly Gln Gly Thr Gln Val 
        115                 120                 125             


Thr Val Ser Ser 
    130         


<210> 29
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Gly Ser Ile Ser Ser Phe Glu Gln 
1               5               


<210> 30
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Phe Arg Ser Asp Gly Ser Thr 
1               5           


<210> 31
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Asn Thr Tyr Pro Val Val Leu Tyr Asn 
1               5                   


<210> 32
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 32
Met Ala Gln Val Thr Leu Lys Glu Ser Gly Gly Gly Leu Val Gln Pro 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Ser Ile Ser Ser 
            20                  25                  30          


Phe Glu Gln Met Ala Trp Tyr Arg Gln Ala Pro Gly Lys Gln Arg Ala 
        35                  40                  45              


Leu Val Ala Arg Phe Arg Ser Asp Gly Ser Thr Lys Tyr Thr Asp Ser 
    50                  55                  60                  


Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Ser Thr Val 
65                  70                  75                  80  


Tyr Leu Gln Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Asn Thr Tyr Pro Val Val Leu Tyr Asn Trp Gly Gln Gly Thr Gln 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 33
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Gly Arg Thr Phe Ser His Ala Thr 
1               5               


<210> 34
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Ile Thr Trp Ser Thr Glu Ser Thr 
1               5               


<210> 35
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Ala Ala Asp Leu Ser Thr Tyr Tyr Gly Ala Ile Asp Thr Gly Ala Asp 
1               5                   10                  15      


Asp Tyr Asp Tyr 
            20  


<210> 36
<211> 129
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 36
Met Ala Gln Val Thr Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Ala 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Arg Thr Phe Ser 
            20                  25                  30          


His Ala Thr Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu 
        35                  40                  45              


Phe Val Ala Arg Ile Thr Trp Ser Thr Glu Ser Thr Tyr Tyr Glu Tyr 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Lys Asp Arg Ala Lys Asn Thr 
65                  70                  75                  80  


Val Tyr Leu Asp Met Asn Arg Leu Lys Pro Glu Asp Thr Ala Ala Tyr 
                85                  90                  95      


Tyr Cys Ala Ala Asp Leu Ser Thr Tyr Tyr Gly Ala Ile Asp Thr Gly 
            100                 105                 110         


Ala Asp Asp Tyr Asp Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210> 37
<211> 129
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 37
Met Ala Gln Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Ala 
1               5                   10                  15      


Gly Gly Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Arg Thr Phe Ser 
            20                  25                  30          


Arg Ala Thr Met Ala Trp Phe Arg Gln Ala Pro Gly Lys Glu Arg Glu 
        35                  40                  45              


Phe Val Ala Gly Ile Arg Trp Ser Thr Glu Ser Thr Tyr Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Arg Ala Lys Asn Thr 
65                  70                  75                  80  


Val Tyr Leu Asp Met Asn Ser Leu Lys Pro Glu Asp Thr Ala Ala Tyr 
                85                  90                  95      


Tyr Cys Ala Thr Asp Leu Ser Thr Tyr Tyr Gly Ala Ile Asp Thr Gly 
            100                 105                 110         


Ala Asp Asp Tyr Asp Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210> 38
<211> 9
<212> PRT
<213> Homo sapiens

<400> 38
Val Met Ala Pro Arg Thr Leu Phe Leu 
1               5                   


